{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T13:10:34Z","timestamp":1700226634178},"reference-count":9,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1080\/10428190310001598017","type":"journal-article","created":{"date-parts":[[2003,11,10]],"date-time":"2003-11-10T17:33:23Z","timestamp":1068485603000},"page":"345-349","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and Tolerability of Alemtuzumab (CAMPATH-1H) in the Salvage Treatment of B-Cell Chronic Lymphocytic Leukemia\u2014Change of Regimen Needed?"],"prefix":"10.1080","volume":"45","author":[{"given":"K","family":"RIEGER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"VON GR\u00dcNHAGEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"FIETZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"THIEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"KNAUF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"CIT0001","first-page":"3257","volume":"16","author":"Lundin J.","year":"1998","journal-title":"a phase II multicenter study\", Journal of Clinical Oncology"},{"key":"CIT0002","first-page":"99, 3554 \u2014 3561","author":"Keating M.J.","year":"2002","journal-title":"Blood"},{"key":"CIT0003","first-page":"15, 1567 \u2014 1574","author":"Osterborg A.","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"CIT0004","first-page":"3891 \u2014 3897","volume":"20","author":"Rai KR.","year":"2002","journal-title":"\"Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received Fludarabine\", Journal of Clininical Oncology"},{"key":"CIT0005","first-page":"87, 4990 \u2014 4997","author":"Cheson B.D.","year":"1996","journal-title":"Blood"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0159"},{"key":"CIT0007","first-page":"70","volume":"17","author":"Pangalis GA.","year":"2000","journal-title":"report on a patient treated thrice in a 3 year period\", Medical Oncology"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1080\/146532401317070899"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2061.x"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428190310001598017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T15:38:52Z","timestamp":1481816332000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428190310001598017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":9,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,8,3]]},"published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1080\/10428190310001598017"],"URL":"https:\/\/doi.org\/10.1080\/10428190310001598017","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}